ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2680

Activation Towards Health Self-Management in Patients with Systemic Lupus Erythematosus

Paul R. Fortin1, Carolyn Neville2, Anne-Sophie Julien3, Murray Rochon4, Davy Eng5, Christine A. Peschken6, Evelyne Vinet7, Marie Hudson8, Doug Smith9, Mark Matsos10, Janet E. Pope11, Ann E. Clarke12, Stephanie Keeling13, J. Antonio Avina-Zubieta14 and Deborah Da Costa15, 1Medicine, CHU de Québec - Université Laval, Québec, QC, Canada, 2Department of Medicine, McGill University Health Center, Montreal, QC, Canada, 3CHU de Québec - Université Laval, Quebec City, QC, Canada, 4Jack Digital, Toronto, ON, Canada, 5Centre de recherche du CHU de Québec - Université Laval - Axe maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec, QC, Canada, 6RR 149G, University of Manitoba, Winnipeg, MB, Canada, 7Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 8Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, 9Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, 10Medicine, McMaster University, Hamilton, ON, Canada, 11Department of Medicine, University of Western Ontario, London, ON, Canada, 12Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 13Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, 14Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 15Medicine, McGill University, Montreal, QC, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: coping, self-management and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster III: Treatment

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity.  Control of disease activity is associated with better outcomes and the ability to self-manage one’s health is an important skill towards this goal. We describe patient’s activation towards health self-management in a population of lupus patients and the factors associated with lower health self-management.

Methods: Patients from the Canadian Network for Improved Outcomes in SLE (CaNIOS) centers participating in the MyLupusGuideTM randomized clinical trial were studied at baseline for their health self-management skills. The study is conducted online after patients receive a written invitation to participate, provide consent, and register online. The Patient Activation Measure (PAM) is a validated self-reported tool designed to measure an individual’s level of confidence, beliefs, knowledge, and skills about managing one’s health. PAM can be used as a continuous score or be divided into four levels with the first two levels indicating insufficient or low activation. We used the PAM as our outcome of interest and compared it to other self-reported data on demographics and psychosocial variables using several validated self-reported instruments (Table 1). Descriptive statistics were performed and univariate linear regressions using mixed model with random effect for site were used for continuous and categorical variables. 

Results: Baseline data collection for MyLupusGuide™ trial was available for analysis on 539 patients from ten centers. Their baseline characteristics are reported in Table 1 with mean (sd) age = 50 (14), female = 91%, Caucasian = 74%. The mean PAM score was moderate at 61.2 (13.5) with a proportion of 16, 20, 42 and 22% in PAM levels 1 to 4 respectively,  indicating insufficient and low activation towards health self-management in 36% of patients. Variables associated with lower PAM scores (Table 1) included shorter disease duration, higher disease activity, lower physical and mental health status, depressive symptoms, less distraction and instrumental coping and more emotional coping, lower lupus self-efficacy and less social support. Categorical variables associated with lower PAM were being work disabled and less medication adherence.

Descriptive statistics

Univariate analyses with PAM

Variable

n

Mean

SD

95% CI

Regression

coefficient

Standard error

Pvalue

Demographic

Age

502

49.64

13.95

(48.42; 50.87)

0.033

0.043

0.44

Computer use (hrs/wk)

521

14.44

13.71

(13.26; 15.62)

-0.069

0.043

0.11

Disease characteristics

Disease duration (years)

532

16.94

11.92

(15.92; 17.95)

0.124

0.049

0.01

SLAQ – activity

539

13.98

7.98

(13.30; 14.65)

-0.319

0.073

<.0001

LDIQ – damage

539

 

3.53

3.06

(3.27; 3.79)

-0.036

0.193

0.85

SF36-PCS – health status

539

38.92

11.94

(37.91; 39.93)

0.298

0.048

<.0001

SF36-MCS –health status

539

43.97

11.26

(43.02; 44.92)

0.217

0.051

<.0001

Psychosocial variables

CESD – depression

537

15.61

10.69

(14.71; 16.52)

-0.316

0.053

<.0001

CHIP# –  Distraction*

538

24.70

6.16

(24.18; 25.22)

0.562

0.091

<.0001

CHIP – Instrumental*

538

29.27

5.27

(28.82; 29.71)

0.778

0.105

<.0001

CHIP – Emotional*

538

19.84

7.60

(19.20; 20.49)

-0.453

0.074

<.0001

Lupus self-efficacy

538

69.00

23.61

(67.00; 71.00)

0.258

0.022

<.0001

MOS social support

538

20.16

6.68

(19.59; 20.72)

0.455

0.084

<.0001

PAM score

539

61.18

13.53

(60.03; 62.32)

na

na

na

Table 1: Baseline demographic, disease and psychosocial characteristics of 539 SLE patients and their association with activation towards health self-management. # CHIP=Coping with Health Injuries and Problems. *Higher values are associated with greater use of each coping related strategy.

Conclusion: More than one third of lupus patients showed low health self-management activation which is a common barrier to improvement of outcomes and health status for patients with lupus.  Reversible factors associated with poor health self-management include lupus disease activity, health status, depression and coping strategies.


Disclosure: P. R. Fortin, None; C. Neville, None; A. S. Julien, None; M. Rochon, None; D. Eng, None; C. A. Peschken, None; E. Vinet, None; M. Hudson, None; D. Smith, None; M. Matsos, None; J. E. Pope, None; A. E. Clarke, None; S. Keeling, None; J. A. Avina-Zubieta, None; D. Da Costa, None.

To cite this abstract in AMA style:

Fortin PR, Neville C, Julien AS, Rochon M, Eng D, Peschken CA, Vinet E, Hudson M, Smith D, Matsos M, Pope JE, Clarke AE, Keeling S, Avina-Zubieta JA, Da Costa D. Activation Towards Health Self-Management in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/activation-towards-health-self-management-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activation-towards-health-self-management-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology